Company / Tangible Book Value per Share
Immunovant, Inc. Tangible Book Value per Share History
FY2018-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$4.08
FY2024
5-year range
$1.07 / $4.08
FY2020-FY2024
Trend
+55.3%
vs FY2023
Sector context
#113 of 211
Health Care
What the data says
At $4.08, Immunovant, Inc.'s tangible book value per share ranks #113 of 211 in the Health Care sector. Improved from $3.82 to $4.08 over the past 2 years.
Based on SEC 10-K filings.
4.08 in FY2024 with a 5-year CAGR of +88.8%.
Improved from $3.82 to $4.08 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- +4.5%
- 5-Year CAGR
- +88.8%
- 10-Year CAGR
- -
Sector benchmark
#113 of 211 in Health CareTop 54% of 211This company $4.08 Sector average $118.77
▼
-96.6% below sector average
Key checks
Key Insights
- In FY2024, tangible book value per share increased 55.3% year-over-year.
- Ranks #113 out of 211 companies in the Health Care sector.
- Lowest tangible book value per share in the period was in FY2018.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $4.08 | +55.3% |
| FY2023 | $2.62 | -31.2% |
| FY2022 | $3.82 | +6.9% |
| FY2021 | $3.57 | +233.0% |
| FY2020 | $1.07 | +531.0% |
| FY2019 | $0.17 | +351.6% |
| FY2018 | -$0.07 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026